Clinical Trials Browser

Phase 1/2 × Carcinoma, Squamous Cell × durvalumab × Clear all

NCT03784066 2024-07-03

DUTRELASCO

Phase 1/2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT03283605 2024-06-28

Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas

Phase 1/2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

NCT03051906 2017-11-22

DUCRO-HN

Phase 1/2 Unknown

Carcinoma, Squamous Cell, Head and Neck Neoplasms